Literature DB >> 12228277

Identification of two distinct subpopulations of Leishmania major-specific T helper 2 cells.

Pascale Kropf1, Shanti Herath, Rita Tewari, Nelofer Syed, Roman Klemenz, Ingrid Müller.   

Abstract

It is widely accepted that a strong Th2 response is responsible for nonhealing Leishmania major infections in BALB/c mice. This Th2 response has been thoroughly documented by measuring the levels of Th2 cytokines produced by CD4(+) T cells present in the lymphoid organs by enzyme-linked immunosorbent assay and PCR. However, the cytokine profile of L. major-specific Th2 cells has never been determined. In this study, we used the recently described Th2 marker T1/ST2 to characterize Th2 cells during the course of nonhealing L. major infection. We analyzed the intracellular cytokine profile of CD4(+) T1/ST2(+) T cells and showed that they clearly displayed a Th2 phenotype, as they expressed interleukin 4 (IL-4), IL-10, and IL-5. In addition, we detected another population of Th2 cells among the CD4(+) T1/ST2(-) T cells that expressed IL-4 and IL-10 but excluded IL-5. In summary, we show here that two type 2 subpopulations are present in the lymphoid organs of L. major-infected BALB/c mice; Th2 cells from both subsets expressed IL-4 and IL-10, but they could be distinguished by their expression of IL-5 and T1/ST2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228277      PMCID: PMC128353          DOI: 10.1128/IAI.70.10.5512-5520.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Commitment factors for T helper cells.

Authors:  A O'Garra
Journal:  Curr Biol       Date:  2000-06-29       Impact factor: 10.834

Review 3.  Flow cytometric measurement of intracellular cytokines.

Authors:  P Pala; T Hussell; P J Openshaw
Journal:  J Immunol Methods       Date:  2000-09-21       Impact factor: 2.303

4.  Clinical relevance of T1-S, an oncogene-inducible, secreted glycoprotein of the immunoglobulin superfamily, in node-negative breast cancer.

Authors:  D Prechtel; N Harbeck; U Berger; H Höfler; A K Werenskiold
Journal:  Lab Invest       Date:  2001-02       Impact factor: 5.662

5.  Regulation and function of T1/ST2 expression on CD4+ T cells: induction of type 2 cytokine production by T1/ST2 cross-linking.

Authors:  C Meisel; K Bonhagen; M Löhning; A J Coyle; J C Gutierrez-Ramos; A Radbruch; T Kamradt
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

6.  Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection.

Authors:  P Kropf; L R Schopf; C L Chung; D Xu; F Y Liew; J P Sypek; I Müller
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

7.  Tumor-associated overexpression of the soluble T1-S receptor in lymph node-negative breast cancer.

Authors:  A K Werenskiold; D Prechtel; N Harbeck; H Höfler
Journal:  Diagn Mol Pathol       Date:  2000-03

8.  T1-deficient and T1-Fc-transgenic mice develop a normal protective Th2-type immune response following infection with Nippostrongylus brasiliensis.

Authors:  K A Senn; K D McCoy; K J Maloy; G Stark; E Fröhli; T Rülicke; R Klemenz
Journal:  Eur J Immunol       Date:  2000-07       Impact factor: 5.532

Review 9.  Progressive disease or protective immunity to Leishmania major infection: the result of a network of stimulatory and inhibitory interactions.

Authors:  R Etges; I Müller
Journal:  J Mol Med (Berl)       Date:  1998-05       Impact factor: 4.599

10.  T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses.

Authors:  M J Townsend; P G Fallon; D J Matthews; H E Jolin; A N McKenzie
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

View more
  10 in total

Review 1.  Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases.

Authors:  Octavie Rostan; Muhammad Imran Arshad; Claire Piquet-Pellorce; Florence Robert-Gangneux; Jean-Pierre Gangneux; Michel Samson
Journal:  Infect Immun       Date:  2015-02-23       Impact factor: 3.441

Review 2.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

3.  Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis.

Authors:  Manuel Modolell; Beak-San Choi; Robert O Ryan; Maggie Hancock; Richard G Titus; Tamrat Abebe; Asrat Hailu; Ingrid Müller; Matthew E Rogers; Charles R M Bangham; Markus Munder; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2009-07-14

4.  Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.

Authors:  Rajatava Basu; Suniti Bhaumik; Arun Kumar Haldar; Kshudiram Naskar; Tripti De; Syamal Kumar Dana; Peter Walden; Syamal Roy
Journal:  Infect Immun       Date:  2007-10-01       Impact factor: 3.441

5.  Signaling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection.

Authors:  P Kropf; S Herath; R Klemenz; I Müller
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

6.  Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival.

Authors:  Matthew Rogers; Pascale Kropf; Beak-San Choi; Rod Dillon; Maria Podinovskaia; Paul Bates; Ingrid Müller
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

7.  Evaluation of T cell responses in healing and nonhealing leishmaniasis reveals differences in T helper cell polarization ex vivo and in vitro.

Authors:  B-S Choi; P Kropf
Journal:  Parasite Immunol       Date:  2009-04       Impact factor: 2.280

8.  L-arginine deprivation impairs Leishmania major-specific T-cell responses.

Authors:  Markus Munder; Beak-San Choi; Matthew Rogers; Pascale Kropf
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

9.  Differential impact of L-arginine deprivation on the activation and effector functions of T cells and macrophages.

Authors:  B-S Choi; I Clara Martinez-Falero; C Corset; M Munder; M Modolell; I Müller; P Kropf
Journal:  J Leukoc Biol       Date:  2008-11-13       Impact factor: 4.962

10.  Age-related alteration of arginase activity impacts on severity of leishmaniasis.

Authors:  Ingrid Müller; Asrat Hailu; Beak-San Choi; Tamrat Abebe; Jose M Fuentes; Markus Munder; Manuel Modolell; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2008-05-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.